Abstract
Importance Although gastrointestinal disease affects gut microbiota and their metabolites associated with dementia risk, the associations between gastrointestinal diseases and the risk of incident dementia are not established.
Objective To examine the associations between 14 gastrointestinal diseases and incident dementia.
Design, setting, and participants Cohort study. This cohort analysis included 352,463 participants free of baseline dementia. Participants joined the UK Biobank study from 2006 to 2010 and were followed up until 2018 or 2021.
Exposures Fourteen baseline gastrointestinal diseases were defined with data from inpatient, primary care, national cancer registries and self-reported data. Polygenic risk score (RPS) and apolipoprotein E (APOE) was constructed by individuals’ genetic data.
Main Outcomes and Measures Primary outcome was incident all-cause dementia ascertained via a inpatient, primary care, and national death registries. Secondary outcomes were risk of common subtypes of dementia, including Alzheimer’s disease and vascular dementia as well as early-onset (i.e., with the onset age < 65 years) and late-onset (≥ 65 years) dementia by diagnosis age.
Results During a median follow-up of 12.4 years among 352,463 participants (mean [SD] age, 55.8 [8.1] years; 54.1% were women), 5648 incident dementia cases were diagnosed. Seven gastrointestinal diseases showed significant associations with an increased risk of dementia after controlling covariates and multiple testing. Compared to individuals without gastrointestinal diseases, the risk of dementia increased from 26% (95% confidence interval 13%-41%) for patients with intestinal diverticular disease to 121% (95% confidence interval 57%-211%) for patients with cirrhosis. The associations were different between certain gastrointestinal diseases and dementia by onset age. The associations appeared to be stronger for cirrhosis (P = 0.001), irritable bowel syndrome (P < 0.001), gastritis and duodenitis (P = 0.002), gastroesophageal reflux disease (P < 0.001), and peptic ulcer (P = 0.030) with early-onset dementia. There were no multiplicative interactions for PRS or APOE (P > 0.05).
Conclusions and relevance This study found associations of several gastrointestinal diseases with an increased risk of incident dementia, especially early-onset dementia. Our findings imply the great importance of dementia prevention among patients with gastrointestinal diseases.
Question Are the gastrointestinal diseases associated with risk of incident dementia?
Findings This large-scaled prospective cohort study including 352,463 participants found that seven gastrointestinal diseases were associated with an increased risk of dementia. The associations of cirrhosis, irritable bowel syndrome, gastritis and duodenitis, gastroesophageal reflux disease, and peptic ulcer appeared to be more strongly associated with early-onset dementia compared to late-onset dementia.
Meaning Seven gastrointestinal diseases are associated with an increased risk of incident dementia and appeared to be stronger for early-onset dementia compared to late-onset dementia.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
SCL is supported by funding from the Swedish Research Council (Vetenskapsradet; Grant Number 2019-00977) and the Swedish Research Council for Health, Working Life and Welfare (Forte; 2018-00123). XL is supported by the Natural Science Fund for Distinguished Young Scholars of Zhejiang Province (LR22H260001) and the National Nature Science Foundation of China (grant no. 82204019).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was conducted with the UK Biobank Resource under application number 66354.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵* Shuai Yuan and Lintao Dan share joint first authorship
Data Availability
The datasets analysed during the current study are available in a public, open access repository (https://www.ukbiobank.ac.uk/).
